Get the Stockscreener App
0.4749
0.04%
0.0002
After Hours:
.47
-0.0049
-1.03%
Anebulo Pharmaceuticals Inc stock is traded at $0.4749, with a volume of 29,085.
It is up +0.04% in the last 24 hours and down -57.97% over the past month.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
See More
Previous Close:
$0.4747
Open:
$0.4689
24h Volume:
29,085
Relative Volume:
0.36
Market Cap:
$19.37M
Revenue:
-
Net Income/Loss:
$-7.92M
P/E Ratio:
-1.583
EPS:
-0.3
Net Cash Flow:
$-7.05M
1W Performance:
-42.17%
1M Performance:
-57.97%
6M Performance:
-80.05%
1Y Performance:
-67.02%
1-Day Range:
$0.465
$0.4849
1-Week Range:
$0.4351
$0.66
52-Week Range:
$0.4351
$3.39
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Name
Anebulo Pharmaceuticals Inc
Sector
Industry
Phone
737 203 5270
Address
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Compare ANEB vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
0.4749 | 19.36M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Anebulo Pharmaceuticals Inc Stock (ANEB) Latest News
Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn - marketscreener.com
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates - Yahoo Finance UK
Anebulo Pharmaceuticals to delist from Nasdaq, deregister with SEC By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SE - PharmiWeb.com
Anebulo Pharmaceuticals stock plunges after announcing Nasdaq delisting plans By Investing.com - Investing.com Nigeria
Anebulo Pharmaceuticals stock plunges after announcing Nasdaq delisting plans - Investing.com
Anebulo Pharmaceuticals Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Anebulo Pharmaceuticals to delist from Nasdaq, deregister with SEC - Investing.com
Anebulo Pharmaceuticals announces intention to voluntarily delist from Nasdaq and deregister with SEC - marketscreener.com
Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC - TradingView
Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC - Business Wire
Anebulo Pharmaceuticals (NASDAQ:ANEB) Trading Down 13.6% – What’s Next? - Defense World
Anebulo Pharmaceuticals (NASDAQ:ANEB) Stock Price Down 13.6% – What’s Next? - Defense World
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Anebulo Pharmaceuticals Completes Oversubscribed Share Repurchase Tender - TipRanks
Anebulo Pharmaceuticals Announces Final Results of Tender Offer - TradingView
Investors tender 4.9M Anebulo shares, only 300,000 accepted at $3.50 - Stock Titan
Anebulo Pharmaceuticals Announces Oversubscribed Self-Tender Offer Results - TipRanks
Anebulo completes oversubscribed share repurchase tender offer - Investing.com
Anebulo Pharmaceuticals Announces Preliminary Tender Offer Results - TradingView
Nearly 4.9M shares chase Anebulo’s $3.50 self-tender - Stock Titan
Anebulo completes oversubscribed share repurchase tender offer By Investing.com - Investing.com UK
Anebulo Pharmaceuticals launches self-tender offer to go private - MSN
How Do Investors Really Feel About Anebulo Pharmaceuticals Inc? - Benzinga
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Down 41.3% in December - Defense World
Dip Buying: Can Anebulo Pharmaceuticals Inc stock hit analyst price targetsJuly 2025 Institutional & Community Verified Watchlist Alerts - Bộ Nội Vụ
Meme Stocks: Will Anebulo Pharmaceuticals Inc stock maintain momentum in 2025July 2025 Highlights & Weekly Stock Breakout Alerts - Bộ Nội Vụ
Valuation Update: Can Anebulo Pharmaceuticals Inc withstand a market correctionJuly 2025 Sentiment & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Published on: 2026-01-12 22:22:11 - Улправда
Trading Recap: Will Anebulo Pharmaceuticals Inc stock attract more institutional investorsBuy Signal & Fast Exit Strategy with Risk Control - moha.gov.vn
Will Anebulo Pharmaceuticals Inc. stock deliver shareholder valueQuarterly Portfolio Review & Daily Growth Stock Tips - ulpravda.ru
Will Anebulo Pharmaceuticals Inc. stock attract more institutional investorsCushioning Options Review & lightweight options for faster days - Улправда
Why Anebulo Pharmaceuticals Inc. stock is favored by top institutionsMarket Sentiment Report & Community Consensus Picks - Улправда
Will Anebulo Pharmaceuticals Inc. stock recover faster than peersJuly 2025 Spike Watch & Stepwise Swing Trade Plans - ulpravda.ru
EPS Watch: Will Anebulo Pharmaceuticals Inc. stock attract more institutional investorsPortfolio Gains Summary & Free Technical Confirmation Trade Alerts - Улправда
Why retail investors pile into Anebulo Pharmaceuticals Inc. stockHigh Beta Stocks & High Return Trading Tips - Улправда
Trend Review: Why Anebulo Pharmaceuticals Inc stock could outperform in 2025Market Weekly Review & Safe Capital Allocation Plans - Bộ Nội Vụ
Mereo BioPharma Group (NASDAQ:MREO) & Anebulo Pharmaceuticals (NASDAQ:ANEB) Financial Comparison - Defense World
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Aug Technicals: What valuation multiples suggest for Anebulo Pharmaceuticals Inc stock2025 Historical Comparison & Safe Entry Momentum Tips - moha.gov.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
How Is The Market Feeling About Anebulo Pharmaceuticals Inc? - Benzinga
We're Hopeful That Anebulo Pharmaceuticals (NASDAQ:ANEB) Will Use Its Cash Wisely - Sahm
Anebulo shifts from reverse stock split to tender offer in go-private plan - Investing.com Nigeria
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Anebulo Pharmaceuticals stock plunges after scrapping reverse split plan By Investing.com - Investing.com South Africa
Anebulo Pharmaceuticals stock plunges after scrapping reverse split plan - Investing.com India
US Stocks Higher; Nasdaq Surges Over 100 Points - Benzinga
Anebulo Pharmaceuticals Launches Self-Tender Offer to Go Private - TipRanks
Anebulo Pharmaceuticals Inc Stock (ANEB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):